Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold
- 26 April 2023
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 255, 115423
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1S10OD010678-01, 1S10RR026377-01, R01CA193609, R01CA240447)
This publication has 45 references indexed in Scilit:
- MDM2 Regulates Vascular Endothelial Growth Factor mRNA Stabilization in HypoxiaMolecular and Cellular Biology, 2011
- MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cellsOncogene, 2011
- Regulation of XIAP Translation and Induction by MDM2 following IrradiationCancer Cell, 2009
- Increased Expression of Apoptosis Inhibitor Protein XIAP Contributes to Anoikis Resistance of Circulating Human Prostate Cancer Metastasis Precursor CellsCancer Research, 2005
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cellsOncogene, 1998
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992